ATE478861T1 - Multizyklische verbindung und verwendungsverfahren - Google Patents
Multizyklische verbindung und verwendungsverfahrenInfo
- Publication number
- ATE478861T1 ATE478861T1 AT07751460T AT07751460T ATE478861T1 AT E478861 T1 ATE478861 T1 AT E478861T1 AT 07751460 T AT07751460 T AT 07751460T AT 07751460 T AT07751460 T AT 07751460T AT E478861 T1 ATE478861 T1 AT E478861T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- disease states
- modulating
- influencing
- kinases
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 102000001253 Protein Kinase Human genes 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 108060006633 protein kinase Proteins 0.000 abstract 2
- 102000003989 Aurora kinases Human genes 0.000 abstract 1
- 108090000433 Aurora kinases Proteins 0.000 abstract 1
- 101100481408 Danio rerio tie2 gene Proteins 0.000 abstract 1
- 101100481410 Mus musculus Tek gene Proteins 0.000 abstract 1
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 230000022131 cell cycle Effects 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steam Or Hot-Water Central Heating Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77650706P | 2006-02-24 | 2006-02-24 | |
| US11/709,994 US7868177B2 (en) | 2006-02-24 | 2007-02-21 | Multi-cyclic compounds and method of use |
| PCT/US2007/004700 WO2007100646A1 (en) | 2006-02-24 | 2007-02-22 | Multi-cyclic compounds and method of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE478861T1 true ATE478861T1 (de) | 2010-09-15 |
Family
ID=38242083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07751460T ATE478861T1 (de) | 2006-02-24 | 2007-02-22 | Multizyklische verbindung und verwendungsverfahren |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7868177B2 (de) |
| EP (1) | EP1994030B1 (de) |
| AT (1) | ATE478861T1 (de) |
| AU (1) | AU2007221294B2 (de) |
| CA (1) | CA2643177C (de) |
| DE (1) | DE602007008694D1 (de) |
| ES (1) | ES2347489T3 (de) |
| WO (1) | WO2007100646A1 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2564355C (en) * | 2004-05-07 | 2012-07-03 | Amgen Inc. | Protein kinase modulators and method of use |
| US7560551B2 (en) * | 2006-01-23 | 2009-07-14 | Amgen Inc. | Aurora kinase modulators and method of use |
| WO2008057280A1 (en) | 2006-10-27 | 2008-05-15 | Amgen Inc. | Multi-cyclic compounds and methods of use |
| GB0801416D0 (en) * | 2008-01-25 | 2008-03-05 | Piramed Ltd | Pharmaceutical compounds |
| TW201030001A (en) * | 2008-11-14 | 2010-08-16 | Amgen Inc | Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors |
| TWI396689B (zh) | 2008-11-14 | 2013-05-21 | Amgen Inc | 作為磷酸二酯酶１０抑制劑之吡衍生物 |
| US8604217B2 (en) | 2009-11-12 | 2013-12-10 | Selvita S.A. | Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
| CN102712601A (zh) * | 2009-11-12 | 2012-10-03 | 赛尔维他股份公司 | 化合物、其制备方法、药物组合物、化合物的用途、用于调节或调控丝氨酸/苏氨酸激酶的方法以及丝氨酸/苏氨酸激酶调节剂 |
| US8957216B2 (en) * | 2010-03-24 | 2015-02-17 | Amitech Therapeutic Solutions, Inc. | Heterocyclic compounds useful for kinase inhibition |
| JP5580492B2 (ja) * | 2011-03-01 | 2014-08-27 | エヌファルマコン，エルエルシー | Ｎ−（４−メトキシフェニル）−１−フェニル−１ｈ−ピラゾール−３−アミンおよび関連化合物の使用 |
| WO2013138617A1 (en) | 2012-03-16 | 2013-09-19 | Axikin Pharmaceuticals, Inc. | 3,5-diaminopyrazole kinase inhibitors |
| EP2994463B1 (de) | 2013-05-07 | 2017-10-25 | Galapagos NV | Neuartige verbindungen und pharmazeutische zusammensetzungen daraus zur behandlung von zystischer fibrose |
| HUE040366T2 (hu) | 2013-08-08 | 2019-03-28 | Galapagos Nv | CFTR modulátor tieno[2,3-c]piránok |
| NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
| US9963444B2 (en) | 2014-05-19 | 2018-05-08 | Northeastern University | N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof |
| TWI703133B (zh) | 2014-12-23 | 2020-09-01 | 美商艾克斯基製藥公司 | ３,５-二胺基吡唑激酶抑制劑 |
| SG11201801856XA (en) | 2015-09-18 | 2018-04-27 | Kaken Pharmaceutical Co Ltd | Biaryl derivative and medicine containing same |
| EP3390387B1 (de) | 2015-12-18 | 2021-11-17 | Bayer Pharma Aktiengesellschaft | Heteroarylbenzimidazolverbindungen |
| WO2017207534A1 (en) | 2016-06-03 | 2017-12-07 | Bayer Pharma Aktiengesellschaft | Substituted heteroarylbenzimidazole compounds |
| AR111281A1 (es) * | 2017-03-17 | 2019-06-26 | Genentech Inc | Compuestos de pirimidinil-piridiloxi-naftil y métodos para tratar enfermedades y trastornos relacionados con ire1 |
| US10689357B2 (en) | 2018-05-08 | 2020-06-23 | Northeastern University | N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and use thereof |
| EP3843741A4 (de) * | 2018-08-30 | 2022-11-30 | The Regents of the University of California | Ire1-kinasehemmer und verwendungen davon |
| TWI831829B (zh) | 2018-09-12 | 2024-02-11 | 美商建南德克公司 | 苯氧基-吡啶基-嘧啶化合物及使用方法 |
| US20220048888A1 (en) | 2018-09-12 | 2022-02-17 | Genentech, Inc. | Pyrimidinyl-heteroaryloxy-naphthyl compounds and methods of use |
| CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| WO2020142612A1 (en) | 2019-01-03 | 2020-07-09 | Genentech, Inc. | Pyrido-pyrimidinone and pteridinone compounds as inhibitors of endoribonuclease inositol requiring enzyme i (ire i alpha) for the treatment of cancer diseases. |
| WO2020168237A1 (en) | 2019-02-14 | 2020-08-20 | Bridgene Biosciences, Inc. | Fgfr inhibitors for the treatment of cancer |
| AR118119A1 (es) | 2019-02-18 | 2021-09-22 | Genentech Inc | Compuestos de pirido-pirimidinilo y métodos de uso |
| EP3983400B1 (de) | 2019-06-11 | 2025-05-28 | Genentech, Inc. | Chinazolinylinverbindungen und verfahren zur verwendung |
| EP4661966A1 (de) * | 2023-02-06 | 2025-12-17 | Type6 Therapeutics, Inc. | Verbindungen, zusammensetzungen und verfahren zur verwendung davon |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0860433B1 (de) | 1995-11-07 | 2002-07-03 | Kirin Beer Kabushiki Kaisha | Chinolinderivate und chinazolinderivate welche die autophosphorylierung des von blutplättchen abstammenden wachstumsfaktorrezeptors inhibiren und sie enthaltende pharmazeutische zusammensetzungen |
| PT1154774E (pt) | 1999-02-10 | 2005-10-31 | Astrazeneca Ab | Derivados de quinazolina como inibidores de angiogenese |
| IL153246A0 (en) | 2000-06-28 | 2003-07-06 | Astrazeneca Ab | Substituted quinazoline derivatives and their use as inhibitors |
| AU9598601A (en) | 2000-10-20 | 2002-04-29 | Eisai Co Ltd | Nitrogenous aromatic ring compounds |
| AU2002313249B2 (en) | 2001-06-22 | 2008-08-21 | Kirin Pharma Kabushiki Kaisha | Quinoline derivative and quinazoline derivate inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| WO2003055491A1 (en) | 2001-12-24 | 2003-07-10 | Astrazeneca Ab | Substituted quinazoline derivatives as inhibitors of aurora kinases |
| EP1517904A4 (de) | 2002-05-23 | 2007-02-21 | Merck & Co Inc | Inhibitoren von mitotischem kinesin |
| MY141867A (en) | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
| GB0219054D0 (en) | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New purine derivatives |
| AU2003286711A1 (en) | 2002-10-25 | 2004-05-13 | Vertex Pharmaceuticals Incorporated | Indazolinone compositions useful as kinase inhibitors |
| EP1670771A4 (de) | 2003-09-30 | 2010-09-01 | Irm Llc | Verbindungen und zusammensetzungen als proteinkinaseinhibitoren |
| DE10349587A1 (de) | 2003-10-24 | 2005-05-25 | Merck Patent Gmbh | Benzimidazolylderivate |
| CA2564355C (en) | 2004-05-07 | 2012-07-03 | Amgen Inc. | Protein kinase modulators and method of use |
| US7989461B2 (en) * | 2005-12-23 | 2011-08-02 | Amgen Inc. | Substituted quinazolinamine compounds for the treatment of cancer |
-
2007
- 2007-02-21 US US11/709,994 patent/US7868177B2/en not_active Expired - Fee Related
- 2007-02-22 WO PCT/US2007/004700 patent/WO2007100646A1/en not_active Ceased
- 2007-02-22 DE DE602007008694T patent/DE602007008694D1/de active Active
- 2007-02-22 AT AT07751460T patent/ATE478861T1/de not_active IP Right Cessation
- 2007-02-22 ES ES07751460T patent/ES2347489T3/es active Active
- 2007-02-22 AU AU2007221294A patent/AU2007221294B2/en not_active Ceased
- 2007-02-22 CA CA2643177A patent/CA2643177C/en not_active Expired - Fee Related
- 2007-02-22 EP EP07751460A patent/EP1994030B1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2643177C (en) | 2011-06-14 |
| DE602007008694D1 (de) | 2010-10-07 |
| US7868177B2 (en) | 2011-01-11 |
| US20070213325A1 (en) | 2007-09-13 |
| ES2347489T3 (es) | 2010-10-29 |
| CA2643177A1 (en) | 2007-09-07 |
| EP1994030B1 (de) | 2010-08-25 |
| AU2007221294A1 (en) | 2007-09-07 |
| EP1994030A1 (de) | 2008-11-26 |
| AU2007221294B2 (en) | 2011-08-25 |
| WO2007100646A1 (en) | 2007-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE478861T1 (de) | Multizyklische verbindung und verwendungsverfahren | |
| MX2009010517A (es) | Moduladores de cinasa aurora y metodos de uso. | |
| MY161884A (en) | Aurora kinase modulators and method of use | |
| MX2010010151A (es) | Moduladores de cinasa aurora y metodo de uso. | |
| MXPA06012613A (es) | Derivados heterociclicos nitrogenados como moduladores de proteina cinasa y uso para el tratamiento de angiogenesis y cancer. | |
| MX2021007157A (es) | Heteroarilamidas utiles como inhibidores de kif18a. | |
| MX419368B (es) | Heteroarilamidas utiles como inhibidores de kif18a | |
| PH12021551409A1 (en) | Kif18a inhibitors | |
| MX2021007104A (es) | Inhibidores de kif18a. | |
| EA200970402A1 (ru) | Триазолопиридазиновые модуляторы протеинкиназ | |
| MY148851A (en) | Dihydropyridine derivatives as useful as protein kinase inhibitors | |
| CR11430A (es) | 4-pirazolil-n-arilpirimidin-2-aminas y 4-pirazolil-n-heteroarilpirimidin-2-aminas como inhibidores de cinasas janus | |
| EA200970738A1 (ru) | Ингибиторы активности akt | |
| EA200970403A1 (ru) | Бициклические триазолы в качестве модуляторов протеинкиназы | |
| BRPI0509069A (pt) | compostos de imidazol para o tratamento de distúrbios neurodegenerativos | |
| UA113156C2 (xx) | Циклобутилзаміщені похідні піролопіридину й піролопіримідину як інгібітори jak | |
| EA201500182A1 (ru) | 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ | |
| BRPI0513405A (pt) | tienopirimidinas úteis como inibidores de aurora quinase | |
| WO2010017240A3 (en) | Aurora kinase modulators and methods of use | |
| MX2009003981A (es) | Agentes moduladores del receptor de calcio. | |
| MA31336B1 (fr) | Inhibiteurs de pi3k alpha a base de pyridopyrimidinone | |
| UA93538C2 (en) | Aurora kinase modulators and method of use | |
| MX2008011576A (es) | Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos. | |
| SG162753A1 (en) | Methods of treating cancer and other conditions or disease states using lfmau and ldt | |
| DE602005023840D1 (de) | Azabicyclooctan-3-onderivate und deren verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |